A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
2016 · Annals of Oncology · 141 citations
https://doi.org/10.1093/annonc/mdw427
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
2.8K
Citations
19
h-index
21
i10-index
Vijay Peddareddigari is an academic researcher from Hospital of the University of Pennsylvania. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & CAR-T cell therapy research & Biosimilars and Bioanalytical Methods. The author has an h-index of 19, co-authored 30 publications.
Click to start Chat